Do you have specific questions about vibegron?

Ask our Urovant Medical Information Team.

Find out the facts about vibegron

Search our summary discussions about clinical trials and use.

Search

Related Information

Report Adverse Events

833-UROVANT (Option 1)

Report Product Complaints

833-UROVANT (Option 1)

Tell us what interests you

How interested are you in learning more about the following topics?

The hypothetical role of targeted gene therapy in modulating BK channel expression
The role of beta-3 adrenergic receptor agonists in the treatment of patients with OAB
A comprehensive treatment overview for OAB
Treatment approaches in OAB
Recent publications on vibegron and OAB

Success!

We’ve received your completed survey. Thanks for participating.

Close

Thank You.

We’ve received your inquiry. Thank you for contacting Urovant Sciences Medical Affairs. We will contact you shortly.

Close

Take Survey

Welcome to
Urovant Sciences Medical Affairs

This site is intended as an educational resource for U.S. healthcare providers. The content may include information about products or potential uses that have not been approved by the U.S. Food and Drug Administration.

This information is not intended to be promotional or deliver medical advice.

Choose an option:

I’m a U.S. healthcare professional I’m a U.S. patient or caregiver